Sanofi India share news, announcements and annual reports
NSE: SANOFIBSE: 500674Pharmaceuticals & BiotechnologySmall Cap
Sanofi India Limited · Formerly Aventis Pharma · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1984 on BSE, May 2003 on NSE
Last close ₹3,204.10up ₹14.60 (0.46%)BSE ₹3,204.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹3,189.50.
30 Oct: open ₹3,265.00, high ₹3,422.60, low ₹3,175.10
52-week range of traded prices to 30 Oct 2026
₹2,758.20Low, 23 Oct 2026₹4,834.00High, 30 Oct 2025
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7,379 Cr614th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.24
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 8.93
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 3.84%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 45.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 57.3%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Jun 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 2,04,44220.0% delivered
Sanofi India share news and announcements
701 announcements, routine notices left out, newest first. Page 11 of 15.
Apr 2015
10 Apr · Disclosure of Voting Pattern - Clause 35A
Mar 2015
Feb 2015
26 Feb · Dividend
Final Dividend and Special One-time dividend will be paid on May 08, 2015.26 Feb · Meeting
Company has fixed Book Closure from April 18, 2015 to April 29, 2015 for the purpose of Final Dividend, Special One-time dividend and Annual General Meeting to be held on April 29, 2015.20 Feb · Dividend
Board of Directors of the Company at their meeting held on February 20, 2015, The Board has recommended : 1) Final dividend of Rs. 24 per Equity share of Rs. 10 for the year ended December 31, 2014. An Interim dividend of Rs.10 per Equity share of Rs. 10 had been paid in August 2014. 2) A Special One-time dividend of Rs. 11 per Equity shares of Rs.10 arising from the profit on the sale of the Company's commercial premises in Mumbai.
Jan 2015
30 Jan · Legal
Exchange had sought clarification from Sanofi India Limited with respect to a news item captioned "Sanofi to set up insulin plant near Hyderabad". The Company has clarified that "The plant is being set up by Shantha Biotechnics Private Limited, a subsidiary of Sanofi, SA, France".30 Jan · Legal
Exchange has sought clarification from Sanofi India Limited with respect to recent news item captioned "Sanofi to set up insulin plant near Hyderabad . In this regard, Exchange have advised the Company to provide clarification/confirmation on the news item in detail including the following: a) Whether such event/negotiations/article stated in published news were taking place? If so, you are advised to provide the said information along with the sequence of events in chronological order and the material impact of this article on the Company. b) Whether company are aware of any information that has not been announced to the Exchanges under clause 36 of the Listing Agreement. The response from the Company is awaited.23 Jan · Board meeting
For approving the audited Accounts for the year ended December 31, 2014 and also to consider recommendation of final dividend for the said financial year.
Nov 2014
Oct 2014
14 Oct · Board meeting
For approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2014.
Aug 2014
Jul 2014
24 Jul · Dividend
Board of Directors of the Company at its meeting held on July 23, 2014, declared an Interim Dividend of Rs. 10(Rupees Ten Only) per Equity Share of Rs.10 for the financial year ending December 31, 2014. The Interim Dividend will be paid on August 14, 2014.23 Jul · Results
18 Jul · Corporate action
Company has fixed Record Date as August 1, 2014 for the purpose of Interim Dividend.10 Jul · Board meeting
For:- (a) Approving the Unaudited Financial Results for the quarter and half year ended June 30, 2014; and (b) Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2014.
May 2014
7 May · Updates
As required by Section 135 of the Companies Act, 2013, the Board of Directors of the Company has, by a resolution passed at it meeting held on April 29, 2014, constituted a Corporate Social Responsibility (CSR) Committee comprising of Mr Rangaswamy R. Iyer, Independent Director, Dr. Shailesh Ayangar, Managing Director and Ms. Virginie Simone Jeanine Verrechia (Ms. Virginie Boucinha), Wholetime Director and Chief Financial Officer. Mr Rangaswamy R. Iyer is the Chairman of the said Committee.2 May · Disclosure of Voting Pattern - Clause 35A
Apr 2014
29 Apr · Results
2 Apr · Board meeting
For approving the Unaudited Financial Results for the quarter ended March 31, 2014 (which is the first quarter of the Company's financial year).
Mar 2014
4 Mar · Dividend
Final Dividend will be paid on May 05, 2014.4 Mar · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from April 18, 2014 to April 29, 2014 (both days inclusive) for the purpose of Payment of Final Dividend & Annual General Meeting (AGM) of the Company to be held on April 29, 2014.
Feb 2014
26 Feb · Dividend
Board of Directors of the Company at its meeting held on February 25, 2014 has recommended Final dividend of Rs.35 per Equity Shares of Rs. 10 for the year ended December 31, 2013.25 Feb · Results
11 Feb · Board meeting
For approving the audited Accounts for the year ended December 31, 2013 and also to consider recommendation of final Dividend for the said financial year.
Nov 2013
Oct 2013
30 Oct · Results
15 Oct · Board meeting
Approving the Unaudited Financial Results for the quarter and nine months ended September 30, 2013.
Sep 2013
Aug 2013
Jul 2013
30 Jul · Dividend
Board of Directors of the Company has, at its meeting held on July 30, 2013 declared an Interim Dividend of Rs.10 (Rupees Ten only) per Equity Share of Rs.10 for the financial year ending December 31, 2013.30 Jul · Dividend
Interim Dividend will be paid on August 20, 2013.30 Jul · Results
25 Jul · Corporate action
In case Interim Dividend is declared by the Board at the Board meeting to be held on July 30, 2013, the Record date for the purpose of payment of such Interim Dividend will be August 06, 2013.10 Jul · Board meeting
For:- (a) Approving the Unaudited Financial Results for the quarter and half year ended 30th June 2013; and (b) Considering the question of declaring an Interim Dividend for the current financial year ending on December 31, 2013.3 Jul · Management
Mr.J. M. Gandhi, Independent Director of the Company, who is a Chartered Accountant has informed the Company that he would be retiring shortly as partner of M/s N. M. Raiji & Co. and after the said retirement he would be joining another reputed Chartered Accountants' firm as a partner. He has further informed that as per the internal code of conduct of the new firm he is not allowed to take up directorship of any company to avoid any possible conflict of interest. Mr. Gandhi has therefore, resigned as a Director of the Company with effect from July 01, 2013.
Jun 2013